Quality of life, salivary cortisol and atopic diseases in young children

• Published in: PloS one 2019-08, Vol.14 (8), p.e0214040-e0214040
• Main Authors: Rolfsjord, Leif Bjarte, Skjerven, Håvard Ove, Bakkeheim, Egil, Berents, Teresa Løvold, Carlsen, Kai-Håkon, Carlsen, Karin C Lødrup
• Format: Article
• Language: English
• Subjects: Age; Allergies; Allergy tests; Asthma; Atopic dermatitis; Biology and Life Sciences; Bronchiolitis; Bronchoconstriction; Bronchopneumonia; Childhood asthma; Children; Chronic illnesses; Clinical medicine; Cortisol; Demographic aspects; Dermatitis; Dermatitis, Atopic - metabolism; Development and progression; Domains; Eczema; Female; Glucocorticoids; Health; Health aspects; Health Surveys; Hormones; Hospitals; Humans; Hydrocortisone; Hydrocortisone - metabolism; Immunology; Infant; Infants; Male; Measurement; Medical tests; Medicine; Medicine and Health Sciences; Pediatric diseases; Pediatrics; People and Places; Population; Proxy; Quality of Life; Questionnaires; Respiratory tract diseases; Saliva - metabolism; Skin; Skin tests; Studies
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0214040

Children with atopic disease may have reduced health-related quality of life (QoL) and morning cortisol. Possible links between QoL, morning cortisol and atopic disease are unclear. We aimed to determine if QoL was associated with morning salivary cortisol at two years of age, and if asthma, atopic dermatitis and/or allergic sensitisation influenced this association. Secondarily, we aimed to determine if QoL at one year of age was associated with salivary cortisol one year later. The Bronchiolitis All SE-Norway study included infants during hospitalisation for acute bronchiolitis in infancy (bronchiolitis group) and population-based control infants (controls). The present study included all 358 subjects with available Infant Toddler Quality of Life Questionnaire (ITQOL) from parents, consisting of 13 domains and morning salivary cortisol at two years of age. Answers from the same 0-100 score questionnaire, with optimal score 100 nine months after enrolment, was also available for 289 of these children at about one year of age. Recurrent bronchial obstruction was used as an asthma proxy. Atopic dermatitis was defined by Hanifin and Rajka criteria and allergic sensitisation by a positive skin prick test. Due to different inclusion criteria, we tested possible interactions with affiliation groups. Associations between QoL and cortisol were analysed by multivariate analyses, stratified by bronchiolitis and control groups due to interaction from affiliation grouping on results. At two years of age, QoL decreased significantly with decreasing cortisol in 8/13 QoL domains in the bronchiolitis group, but only with General health in the controls. The associations in the bronchiolitis group showed 0.06-0.19 percentage points changes per nmol/L cortisol for each of the eight domains (p-values 0.0001-0.034). The associations remained significant but diminished by independently including recurrent bronchial obstruction and atopic dermatitis, but remained unchanged by allergic sensitisation. In the bronchiolitis group only, 7/13 age and gender adjusted QoL domains in one-year old children were lower with lower cortisol levels at two years of age (p = 0.0005-0.04). At two years, most QoL domains decreased with lower salivary cortisol among children who had been hospitalised for acute bronchiolitis in infancy, but for one domain only among controls. Recurrent bronchial obstruction and to a lesser extent atopic dermatitis, weakened these associations that nevertheless rema